Galmed Pharmaceuticals Ltd. (GLMD) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
GLMD Revenue Growth
GLMD Revenue Analysis (2013–2024)
As of May 8, 2026, Galmed Pharmaceuticals Ltd. (GLMD) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q2 2025) recorded $0 in revenue.
Looking at the longer-term picture, GLMD's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $2.0 million in 2018.
When compared to Healthcare sector peers including MDGL (+256.8% YoY), AKBA (+25.7% YoY), and HALO (+37.6% YoY). Compare GLMD vs MDGL →
GLMD Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| GLMDCurrent | $0 | - | - | - | |
 MDGL | $958M | +256.8% | - | -31.3% | |
 AKBA | $236M | +25.7% | -4.3% | 9.9% | |
 HALO | $1.4B | +37.6% | +39.2% | 58.4% | |
 CPRX | $589M | +19.8% | +37.7% | 43.8% | |
 GNFT | $67M | +9.8% | +16.8% | 4.9% |
GLMD Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $-83,000 | - | $-6,278,000 | - |
| 2023 | $0 | - | $-31,000 | - | $7.5M | - |
| 2022 | $0 | - | $-35,000 | - | $-17,651,000 | - |
| 2021 | $0 | - | $-42,000 | - | $-32,881,000 | - |
| 2020 | $0 | - | $-39,000 | - | $-30,210,000 | - |
| 2019 | $0 | -100.0% | $-35,000 | - | $-22,376,000 | - |
| 2018 | $2.0M | +87.8% | $2.0M | 100.0% | $-10,715,000 | -525.8% |
| 2017 | $1.1M | +132.3% | $1.1M | 100.0% | $-12,364,000 | -1139.5% |
| 2016 | $467K | - | $467K | 100.0% | $-16,882,000 | -3615.0% |
| 2015 | $0 | - | $-50,000 | - | $-10,875,000 | - |
See GLMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GLMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GLMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGLMD — Frequently Asked Questions
Quick answers to the most common questions about buying GLMD stock.
Is GLMD's revenue growth accelerating or slowing?
GLMD TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is GLMD's long-term revenue growth rate?
Galmed Pharmaceuticals Ltd.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is GLMD's revenue distributed by segment?
GLMD reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.